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The involvement of transforming growth factor-b
isoforms in the induction of the regressing phase
(catagen) of human hair follicles were examined
in vivo. In the growing phase (anagen), transforming
growth factor-b1 was detected at the hair cuticle and
connective tissue sheath. Transforming growth fac-
tor-b2 was restricted to the outermost cell layer of
the outer root sheath. Transforming growth factor-
b3 was observed in the precortical hair matrix of
anagen hair follicles. During the anagen±catagen
transition phase, strong transforming growth factor-
b2 immunoreactivity appeared in the lower bulb
matrix cells adjacent to the dermal papilla. In add-
ition, transforming growth factor-b2 and transform-
ing growth factor-b type II receptor were
colocalized in the regressing epithelial strands, where
terminal deoxynucleotidyl transferase-mediated
deoxyuridine triphosphate nick end-labeling-positive
apoptotic cells were also found. Transforming
growth factor-b1 and transforming growth factor-b3
were mostly negative in the strand. Using an organ
culture system, we investigated whether transform-
ing growth factor-b2 and its antagonists affected the
transition process. Elongation of hair was signi®-
cantly suppressed by transforming growth factor-b2.
Next, a neutralizing antibody and fetuin, a potent
transforming growth factor-b antagonist was tested.
In the presence of the antibody as well as fetuin, hair
follicles were markedly elongated in a concentration-
dependent manner. These results strongly suggest
that transforming growth factor-b2 plays an essential
part in the induction of the catagen phase of the
human hair cycle. Key words: apoptosis/catagen induc-
tion/hair cycle/transforming growth factor-b. J Invest
Dermatol 118:993±997, 2002
T
ransforming growth factor (TGF)-b is a family of
multifunctional cytokines. Three isoforms, designated
as TGF-b1, TGF-b2, and TGF-b3, are present in
mammals (Roberts and Sporn, 1990). The signals of
all three TGF-b are mediated through a heteromeric
complex of type I and type II TGF-b receptors, which have serine/
threonine kinase activities (Massague, 1998). Recently, it was
revealed that the signal transduction downstream of the TGF-b
receptors involves the Smad family (Hoodless and Wrana, 1998).
TGF-b regulate various physiologic reactions, such as cellular
growth and differentiation, morphogenesis, angiogenesis, adhesion
and chemotaxis, extracellular matrix formation (Massague et al,
1992), and apoptotic cell death (Oberhammer et al, 1992; Ohta et
al, 1994). The three TGF-b isoforms are differentially expressed in
many tissues, including whisker follicles during mouse embryogen-
esis (Schmid et al, 1991). Three null mutation studies revealed
characteristic and only partially overlapping phenotypes (Letterio et
al, 1994; Dickson et al, 1995; Kaartinen et al, 1995; Snaford et al,
1997), suggesting that these isoforms have distinct functions,
depending on their expression sites, in embryogenesis, morpho-
genesis, and various biologic reactions.
The hair cycle is a highly regulated process. Three phases
have been de®ned for the mammalian hair cycle: anagen
(growing phase), catagen (regressing phase), and telogen (resting
phase) (Kligman, 1959). It is important to understand the
mechanism of hair cycle regulation in order to prevent hair loss.
Recent investigations have revealed involvement of the Shh and
Wnt signal pathways in hair morphogenesis, as well as in the
hair induction process (St-Jacques et al, 1998; Chiang et al,
1999; Millar et al, 1999). A previous study using a single hair
follicle organ culture clearly demonstrated that TGF-b could
induce morphologic changes and apoptotic cell death indistin-
guishable from those seen in human catagen hair follicles (Soma
et al, 1998).
In this study, we report that among TGF-b isoforms, TGF-b2 is
the key molecule that modulates catagen entry in the human hair
cycle in vivo and in vitro. Furthermore, it is shown that TGF-b
antagonists suppress catagen-like morphologic changes, resulting in
the elongation of hair follicles.
MATERIALS AND METHODS
Materials Williams E medium, Dulbecco's modi®ed Eagle's medium,
fetal bovine serum, penicillin, streptomycin, and fungizone were supplied
by Life Technologies (Rockville, MD). All other tissue culture reagents,
including bovine fetuin, were purchased from Sigma (St Louis, MO).
Tissue preparation Human scalp skin specimens were obtained from
plastic surgery. Scalp skin pieces and isolated hair follicles washed with
ice-cold phosphate-buffered saline (PBS) were ®xed with 4%
paraformaldehyde in phosphate buffer (pH 7.4) at 4°C for 4 h, and
embedded in paraf®n wax. Serial sections of 3±5 mm were cut and
mounted on slides precoated with silane (Matsunami, Tokyo, Japan). For
double staining of TGF-b receptor type II and apoptotic cells, frozen
sections with 10 mm were used.
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Keratin adsorption and antigen adsorption of antibodies All
antibodies were subjected to keratin treatment in order to reduce
nonspeci®c binding of antibodies to epidermal and follicular keratins.
Human corni®ed cell extract was washed three times with Tris-buffered
(pH 7.6) saline, once with acetone, and then air-dried. Antibodies
diluted to the working concentration were incubated with 100 mg per
ml keratin powder in PBS containing 3% bovine serum albumin with
vigorous shaking at 4°C overnight. After centrifugation, supernatants
were collected for immunohistochemistry. Rabbit polyclonal antibodies
speci®c to human TGF-b1 (SC-146), TGF-b2 (SC-90), TGF-b3 (SC-
82), and TGF-b receptor type II (SC-220) were purchased from Santa
Cruz (Santa Cruz Biotechnology, Santa Cruz, CA). Anti-TGF-b1
antibody was used at a dilution of 1:20, and anti-TGF-b2, anti-TGF-b3,
and TGF-b type II receptor antibodies were used at 1:100. In order to
test the speci®city of antibodies, each antibody was incubated with
100 mg per ml of an appropriate immunogen peptide for 1 h at room
temperature. After centrifugation, the supernatant was adjusted to the
same concentration as the original antibody, and used in
immunohistochemistry as a negative control. Peptides used for
immunoadsorption were SC-146P, SC-90P, SC-82P, and SC-220P
(Santa Cruz) for anti-TGF-b1, anti-TGF-b2, anti-TGF-b3, and anti-
TGF-b, type II receptor antibodies, respectively.
Immunohistochemical detection of TGF-b isoforms Paraf®n-
embedded tissue sections were deparaf®nized, rehydrated, and
equilibrated in PBS for 10 min at room temperature. After blocking with
10% normal goat serum at room temperature for 20 min, sections were
incubated with each antibody treated with keratin powder at 4°C
overnight. For TGF-b1 immunostaining, but not others, tissue sections
were moderately digested with 10 mg per ml proteinase K (Nakalai
Tesque, Tokyo, Japan) in PBS at 37°C for 30 min before the blocking
procedure. A biotinylated rabbit anti-mouse IgG (Nichirei, Tokyo,
Japan) was used as a secondary antibody followed by reaction with
peroxidase-conjugated streptavidin (Nichirei). Tetramethylbenzidine
(Kirkegaard & Perry Laboratories Inc., Gaithersburg, MD) was used as a
color-developing reagent in Tris-buffer (pH 7.6) containing 0.01%
H2O2. The sections were counterstained with nuclear fast red (Sigma).
In the case of anagen hairs, more than 60 follicles from six patients
(minimum 10 follicles from each patient) were used for each antibody
staining. For catagen hairs, 20 follicles (two to four catagen follicles per
patients) were used for the staining.
Double immunodetection of terminal deoxynucleotidyltransferase-
mediated deoxyuridine triphosphate-biotin nick end labeling
(TUNEL)-positive cells and TGF-b receptor type II For
visualization of apoptotic cells and TGF-b receptor type II, cryostat
sections were ®xed with 4% paraformaldehyde in phosphate buffer
(pH 7.4) at room temperature for 20 min and subjected to
immunohistochemical staining using Texas Redâ dye-conjugated anti-
rabbit IgG (donkey) as a secondary antibody. TUNEL reaction was
performed using a ¯uorescein in situ cell death detection kit (Roche
Diagnostics, Mannheim, Germany) according to the manufacturer's
instructions.
Isolation and culture of human hair follicles Human hair follicles
were isolated and cultured as previously described (Soma et al, 1998).
Isolated anagen follicles were maintained in 1 ml of Williams E medium
containing 100 U penicillin per ml, 10 mg streptomycin per ml, and
2.5 mg fungizone per ml (basal medium) at 37°C in 5% CO2 and 95%
air. To evaluate the effects of TGF-b antagonistic molecules, hair follicles
were incubated with 10 or 20 mg per ml of anti-TGF-b neutralizing
antibody (Genzyme, Cambridge, MA) or 20 mg per ml of normal mouse
IgG1 (Chemicon, Temecula CA). In separate experiments, fetal bovine
serum fetuin or bovine serum albumin was added to the basal medium.
Fetuin is a potent TGF-b antagonist, having a homologous domain to
TGF-b type II receptor binding site (Demetrious et al, 1996). Culture
medium was replaced every 3 d unless otherwise mentioned. Tissue
sections of hair follicles were prepared as described above. Ten hair
follicles were used for each sample concentration. The same experiment
was repeated three times using hair follicles obtained from three different
patients.
RESULTS
Each TGF-b isoform is localized in distinct portions of
human anagen hair follicles In late anagen hair follicles, TGF-
b1 immunoreactivity was detected in the hair cuticle and the
connective tissue sheath cells (Fig 1A). The hair cuticle was also
strongly positive for anti-TGF-b1 antibody. TGF-b2 was detected
at the outermost layer of outer root sheath cells, which showed an
elongated and palisade structure (Fig 1B). The lower bulb portion
of anagen hair follicles was negative for TGF-b2. Anti-TGF-b3
antibody showed strong staining at the hair cortex and the hair
cuticle in the keratogenous zone of the upper hair bulb (Fig 1C).
Hair medulla was not stained (data not shown). Treatment of each
antibody with the appropriate blocking peptide completely
abolished the positive staining for TGF-b1, TGF-b2, or TGF-
b3, on hair follicles, con®rming the speci®city of each antibody
Figure 1. Immunohistochemical detection of
TGF-b isoforms in human anagen hair
follicles. Human anagen hair sections were
prepared and stained with antibodies speci®c to
TGF-b isoforms. TGF-b1 was seen in the
connective tissue sheath cells (indicated by arrows)
and the hair cuticle (indicated by arrowheads) (A).
TGF-b2 immunoreactivity was detected at the
outermost cell layer of the outer root sheath in
late anagen (indicated by arrowheads) (B). TGF-b3
immunoreactivity was found in the keratinizing
matrix cells (C). Scale bars: 100 mm.
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used in this study. We also con®rmed loss of the positive staining
when the primary antibodies were omitted (data not shown).
TGF-b isoforms change their localization at catagen In late
catagen hair follicles, only a few cells in the connective tissue sheath
were positive for TGF-b1 (Fig 2A). Regressing hair follicles were
not stained by anti-TGF-b1 antibody. Strong TGF-b2
immunoreactivity was detected in the regressing epithelial strand
(Fig 2B), indicating an important role of TGF-b2 in the catagen
progression. Speci®c staining for TGF-b3 seen in the keratogenous
zone in the anagen phase was no longer observed in catagen hair
follicles (Fig 2C). Weak staining was still observed in the inner cell
layers of the outer root sheath.
Apoptotic cells are present in the type II receptor-positive
regressing epithelial strand In order to analyze involvement
of the TGF-b signal pathway in apoptotic processes, double
staining for TGF-b type II receptor and TUNEL-positive cells
was carried out. In late catagen hair follicles, TGF-b type II
receptor was found in a relatively wide range of the epithelial
component, including the edge of club hair and regressing
epithelial strand (Fig 3A). TUNEL-positive apoptotic cells were
also detected in this area, although their localization was more
restricted (Fig 3B). The superimposed image showed that
TUNEL-positive cells were found in the TGF-b type II
receptor-positive cells (Fig 3C).
Figure 2. Immunohistochemical detection of
TGF-b isoforms in human catagen hair
follicles. Catagen hair follicles were identi®ed
from serial sections and immunostained with each
isoform-speci®c antibody. Only a few positive
cells for TGF-b1 were observed in the connective
tissue sheath of catagen hair (indicated by arrows)
(A). TGF-b2 immunoreactivity was detected in
the regressing epithelial strand (ES) in late catagen
(indicated by arrowheads) (B). TGF-b3
immunoreactivity was no longer observed in the
catagen hair (C). Scale bars: 100 mm.
Figure 3. TUNEL-positive cells localized
among the TGF-b type II receptor-positive
cells. Human catagen hair follicles were isolated
and double staining was carried out for the
detection of TGF-b type II receptor and
apoptotic cells. TGF-b type II receptor
immunoreactivity was found in a broad area of
regressing epithelial component (A) including
epithelial strand (ES). TUNEL-positive apoptotic
cells were detected in the same area (B). Dermal
papilla cells (DP) were negative for both stainings.
A superposition of images (A) and (B) is shown in
(C). Scale bars: 100 mm.
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Strong deposition of TGF-b2 occurs in the hair bulb during
the transition phase In order to determine whether TGF-b2
plays a part in the early catagen phase, hair follicles at the
transitional stages were isolated from human scalp skin by
microdissection based on the early morphologic changes of hair
bulbs. They were easily detectable as upward removal of the
hair shaft from the dermal papilla cells (DP), decrease of hair
color due to the downregulation of melanogenesis and increased
thickness of the connective tissue sheath. Hair follicles were
immediately ®xed and stained for TGF-b2. Figure 4 shows an
example of a series of isolated hair follicles exhibiting anagen±
catagen transition (Fig 4A±D). In the late anagen hair follicle, a
faint staining for TGF-b2 could be detected around the
germinative matrix cells (Fig 4E). In the very early catagen
hair follicles, which are characterized by the removal of
melanocytes above the DP (Fig 4B, C), strong TGF-b2
deposition was demonstrated in the lower part of the
boundary area between the DP and the germinative matrix
cells (Fig 4F, G). With the progression of the catagen phase,
the intercellular space of DP became positive and the basal plate
was mostly positive for TGF-b (Fig 4H). In the organ culture
system, we con®rmed essentially the same TGF-b2 staining
pattern, starting as early as at 3 d of culture (data not shown).
Effects of TGF-b and its neutralizing antibody on hair
growth and morphology in organ culture system We then
tested the effect of TGF-b2 on the elongation of hair follicles
cultured in vitro. Hair elongation was suppressed in the presence of
Figure 5. Effects of TGF-b2 and TGF-b antagonists on hair elongation. Anagen hair follicles were isolated and cultured in the presence of
TGF-b2 (A), neutralizing antibody (B), or a potent TGF-b antagonist, fetuin (C). Cultures were performed for 5 d for (A, B), or 8 d for (C). As
controls, the same concentrations of normal rabbit IgG was used for (B) and bovine serum albumin was added to (C). The length of hair follicles was
measured under a microscope. Ten follicles were used for each concentration. Results are expressed as the mean 6 SD. *p < 0.05, **p < 0.01 (one-
way ANOVA and Dunnett's post-hoc procedure).
Figure 4. Upregulation of TGF-b2 in the boundary area of germinative hair matrix cells and DP cells in early catagen hair follicles. Hair
follicles were isolated and classi®ed according to the degree of catagen morphology. In late anagen hair follicles (A), the germinative matrix cells and
DP cells were almost negative for TGF-b2 immunoreactivity (E). In early catagen hair follicles characterized by the upward movement of the hair shaft
from the DP (B, C), strong immunoreactivity for TGF-b2 was observed in the DP around the germinative matrix cells (F, G). As the catagen phase
progressed, the DP and the basal plate became positive for TGF-b2 (H).Scale bars: 40 mm.
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TGF-b2, especially at 50 ng per ml concentration (p < 0.01)
(Fig 5A). Overall elongation of control hair follicles reached
1.5 mm from the starting point, whereas that of TGF-b2-treated
follicles was approximately 1.2 mm during the 5 d culture period.
The anti-TGF-b neutralizing antibody (Genzyme), which inhibits
TGF-b action, can neutralize all three TGF-b isoforms in cell
culture (Dasch et al, 1989). To block endogenous TGF-b2 seen
around the germinative matrix cells, we used this antibody in our
organ culture system. Hair growth was stimulated in the presence
of the neutralizing antibody and showed about 7% (p < 0.1) and
11% increases (p < 0.01) at the concentrations of 10 mg per ml and
20 mg per ml of the antibody, respectively (Fig 5B).
A recent study revealed that fetuin and some synthetic peptides
derived from both fetuin and TGF-b type II receptor could work as
antagonists for TGF-b activity (Demetrious et al, 1996). We also
examined whether fetuin could have similar effect, as seen by the
neutralizing antibody. In the presence of fetuin, hair growth was
markedly and signi®cantly stimulated at day 8 in a concentration-
dependent manner, compared with the effect of bovine serum
albumin (Fig 5C).
DISCUSSION
We examined the regressing phase of the human hair cycle to
identify the key molecule responsible for catagen induction. Our
results revealed that TGF-b2 plays an essential part in the induction
of catagen. TGF-b is not only a potent growth inhibitor (Glick et
al, 1991; Alexandrow and Moses, 1995) but also an apoptosis
inducer (Oberhammer et al, 1992; Ohta et al, 1994) of epithelial
cells, including interfollicular and follicular epithelium. Recently,
we demonstrated that TGF-b2 suppressed the proliferation of hair
follicle cells and accelerated the catagen-like morphologic changes
associated with increased apoptosis of these cells (Soma et al, 1998).
The most striking ®nding of our study was the strong deposition of
TGF-b2 at the boundary area between the germinative matrix and
the DP during the anagen±catagen transition (Fig 3). The
germinative matrix cells cease to grow as soon as the hair follicle
enters the catagen phase. In this study, it was also demonstrated that
TGF-b2 markedly inhibited hair elongation in the organ culture
system. Furthermore, as the catagen phase proceeds, TGF-b2- and
TUNEL-positive cells were found in similar areas of the regressing
epithelial strand (Figs 2B and 3B), where the TGF-b type II
receptor was strongly positive (Fig 3A). Taking all these results
into account, induction of catagen is suggested to take place as
follows. In late anagen, deposition of TGF-b2 occurs around the
germinative matrix cells, where proliferating cells reside. High
levels of TGF-b2 result in growth inhibition and further lead to the
apoptosis of these cells.
An inductive role of TGF-b2 is also supported by the inhibition
studies. We tried to suppress TGF-b action by using two
antagonistic molecules, a neutralizing antibody and fetuin. In the
culture system, we found that the catagen-like morphologic
changes well re¯ected the in vivo condition, with the upregulation
of TGF-b2 and the same deposition pattern of TGF-b2 in the
lower part of the hair bulb. Both antagonistic molecules promoted
remarkable hair follicle elongation, suggesting suppression of the
catagen entry process by TGF-b2. These lines of evidence strongly
indicate that TGF-b2 plays an essential part in catagen induction of
human hair follicles. Furthermore, inhibition of TGF-b action can
prolong the anagen phase in human hair.
TGF-b may also be involved in the early catagen signaling in the
mouse hair cycle. TGF-b2 was expressed immediately before
catagen (Seiberg et al, 1995). Moreover, TGF-b1 injection in mice
resulted in the inhibition of anagen and caused premature catagen
induction (Foitzik et al, 2000). Maximal immunoreactivity as well
as mRNA levels of TGF-b type II receptor was observed in the
anagen VI to early catagen transformation in the mouse hair cycle
(Paus et al, 1997).
In summary, this study has elucidated the spatiotemporal
localization of TGF-b isoforms during the human hair cycle.
Upregulation and speci®c localization of TGF-b2 in the anagen±
catagen transition phase would be the key to initiate the process of
catagen. The effect of antagonistic molecules to TGF-b strongly
supports this hypothesis, providing the basis for a fuller under-
standing of hair cycle regulation.
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